PharmaRoth Labs Inc. | Income Statement
Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
153.90
529.00
87.00
263.50
181.60
Cost of Goods Sold (COGS) incl. D&A
119.70
212.60
60.10
155.40
108.90
Gross Income
34.20
316.40
26.90
108.00
72.60
SG&A Expense
460.90
609.00
396.90
340.90
164.20
EBIT
426.70
292.50
370.00
232.90
91.60
Pretax Income
426.70
292.50
370.00
232.90
91.60
Consolidated Net Income
426.70
292.50
370.00
232.90
91.60
Net Income
425.20
291.00
369.80
232.80
91.50
Net Income After Extraordinaries
425.20
291.00
369.80
232.80
91.50
Net Income Available to Common
425.20
291.00
369.80
232.80
91.50
EPS (Basic)
0.00
0.00
0.00
0.00
0.00
Basic Shares Outstanding
219,383.60
280,685.60
322,421.90
364,938.00
380,095.30
EPS (Diluted)
0.00
0.00
0.00
0.00
0.00
Diluted Shares Outstanding
219,383.60
280,685.60
322,421.90
364,938.00
380,095.30
EBITDA
424.60
292.10
370.00
232.90
91.60
Minority Interest Expense
1.50
1.60
0.20
0.10
0.10
About PharmaRoth Labs
View Profile
